Cargando…

Screening ANLN and ASPM as bladder urothelial carcinoma-related biomarkers based on weighted gene co-expression network analysis

Introduction: Bladder cancer (BLCA) is one of the most common malignancies in the urinary system with a poor prognosis and high treatment costs. Identifying potential prognostic biomarkers is significant for exploring new therapeutic and predictive targets of BLCA. Methods: In this study, we screene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Tenghao, Chi, Zepai, Liu, Guoyuan, Hong, Xuwei, Cao, Sizhe, Cheng, Kequan, Zhang, Yonghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083327/ https://www.ncbi.nlm.nih.gov/pubmed/37051591 http://dx.doi.org/10.3389/fgene.2023.1107625

Ejemplares similares

Predictive model for urosepsis in patients with Upper Urinary Tract Calculi based on ultrasonography and urinalysis using artificial intelligence learning
por: Hong, Xuwei, et al.
Publicado: (2022)

Influencing factors for mortality in prostate cancer patients with T1 and T2 stage: a retrospective cohort study
por: Hong, Xuwei, et al.
Publicado: (2023)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
por: Cui, Zhiwei, et al.
Publicado: (2022)

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
por: Su, Qiongli, et al.
Publicado: (2022)

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Construction of 3D and 2D contrast-enhanced CT radiomics for prediction of CGB3 expression level and clinical prognosis in bladder cancer
por: Zhang, Yuanfeng, et al.
Publicado: (2023)

Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
por: Wu, Weichu, et al.
Publicado: (2023)

A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer
por: Hong, Xuwei, et al.
Publicado: (2023)

The Multiple Mitotic Roles of the ASPM Orthologous Proteins: Insight into the Etiology of ASPM-Dependent Microcephaly
por: Razuvaeva, Alyona V., et al.
Publicado: (2023)

Overexpression of ANLN in lung adenocarcinoma is associated with metastasis
por: Xu, Jie, et al.
Publicado: (2019)

Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis
por: Cai, Dawei, et al.
Publicado: (2022)

Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Primary Urothelial Bladder Cancer in a Young Patient: A Case Report and Review of the Literature
por: Alhubaishy, Bandar, et al.
Publicado: (2021)

Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma
por: Wang, Yaxuan, et al.
Publicado: (2022)

Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma
por: Elhawary, Nasser A, et al.
Publicado: (2023)

KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration
por: Ma, Sai, et al.
Publicado: (2023)

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation
por: Yu, Yang, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in crohn’s disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
por: Chen, Huaian, et al.
Publicado: (2023)

Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis
por: Campregher, Paulo Vidal, et al.
Publicado: (2015)

The molecular landscape of ASPM mutations in primary microcephaly
por: Nicholas, A K, et al.
Publicado: (2009)

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
por: Wu, Sheng, et al.
Publicado: (2019)

ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis
por: Xiao, Yu, et al.
Publicado: (2022)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers
por: Tsai, Kelvin K., et al.
Publicado: (2023)

Genetic interactions between ANLN and KDR are prognostic for breast cancer survival
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers
por: Shi, Yanlong, et al.
Publicado: (2022)

Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation
por: Sheng, Li, et al.
Publicado: (2023)

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
por: Magnusson, Kristina, et al.
Publicado: (2016)

The Derived Allele of ASPM Is Associated with Lexical Tone Perception
por: Wong, Patrick C. M., et al.
Publicado: (2012)

Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
por: Zhang, Yuanfeng, et al.
Publicado: (2023)

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test
por: Kavcic, Niko, et al.
Publicado: (2022)

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
por: Cao, Yu-Fei, et al.
Publicado: (2022)

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019)

Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma
por: Liu, Zhihua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bluc2mdr0r7l5nggedb9g151j7